HELSINKI (AP) — Danish drugmaker Novo Nordisk has revised up its offer for Belgian biotech company Ablynx as it looks to find growth opportunities beyond its core business. The Copenhagen-based company said Monday it is offering up to 30.50 euros for each Ablynx share, valuing the company at…
News
- Novo Nordisk revises up offer for Ablynx to $3.1 billion
- Celgene, Dave & Buster's slide while Kohl's and Crocs rise
The action camera maker said demand was weak over the holidays, and said it's lowering its forecast and cutting jobs. Celgene Corp., down 81 cents to $104.18. The biotech drugmaker said it will buy Impact Biomedicines for $1.1 billion, with up to $5.9 billion in other potential payments.
- bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect and treat multiple cancers at the cellular level at Biotech Showcase™ 2018, an annual investor…
- Promising SA biotech to get global audience with potential investors
A San Antonio-based biotech companies has secured an invitation to a West Coast event that could elevate it from a promising upstart to a player on the international stage. BioAffinity Technologies, a privately held cancer diagnostics company that moved its headquarters to San Antonio in March…
- Dow 25000: Index keeps rolling with another milestone
This tamale-making hack may change your next tamalada... mysa; Dog caught in middle of family's New Year's Eve fireworks... mysa; San Antonio child sings ... The Nasdaq composite, which is heavily weighted with technology and biotech companies, added 12.38 points, or 0.2 percent, to 7,077.91.…